WATERTOWN, Mass., Sept. 28, 2016 -- For the seventh year in a row, pediatricians ranked temporal artery thermometry (TAT) number one in overall preference over any other thermometry method, according to a recent survey of physicians. Of the 268 survey respondents, 40.5 percent ranked TAT number one based on overall performance, compared to rectal, ear, oral and axillary thermometry. In addition, more than half (57.3 percent) of pediatricians ranked TAT number one in ease of use.
The new study further shows that Exergen is used and recommended more than any other thermometer brand – 42 percent of pediatricians use the Exergen TAT and 36 percent recommend it to their patients, ranking highest in both categories. In addition, the results show that nearly two-thirds of pediatricians (64.4 percent) who use or recommend Exergen temporal artery thermometers do so for patients of all ages, the highest percentage of any thermometer.
“We are pleased to see that pediatricians continue to embrace and recommend temporal artery thermometry over all other methods, and that the number of those physicians is steadily increasing,” said Dr. Francesco Pompei, CEO of Exergen Corporation. "With more than 60 clinical studies supporting its accuracy, physicians have come to trust and rely on the TemporalScanner. It is non-invasive, easy to use and accurate, which enhances the physician-patient bond."
Survey respondents noted strengths of temporal artery thermometry, including ease of use and accuracy. The survey also captured pediatricians' commentary about temporal artery thermometry. According to one physician respondent, "Temporal Artery Exergen has made my life very easy!" Another respondent said, “Temporal Artery is easy to use for nurse, patient and family.”
The survey was conducted by Pragmatic Research, Inc. and pediatricians were not told that it was sponsored by Exergen. The results were consistent with other independent research involving nurses and other healthcare professionals in various clinical settings.
ABOUT EXERGEN CORPORATION
Exergen Corporation is a recognized world leader in industrial and medical non-invasive temperature technology. The company manufactures and markets TemporalScanner thermometer models for hospitals and clinics, and consumer models sold in major retailers nationwide. Nearly two billion temperatures are taken each year with Exergen TemporalScanners in thousands of hospitals, clinics and pediatricians' offices across the country, as well as in millions of homes. It is the #1 preference of pediatricians, nurses, and mothers and is the #1 selling retail thermometer. The Exergen TemporalScanner’s performance is supported by more than 60 peer-reviewed published studies covering all ages from preterm infants to geriatrics, and all care areas from hospitals to homes. For additional information, visit www.exergen.com.
Contact: Victoria Day Rosica Public Relations [email protected] P: 201.843.5600 F: 201.843.5680 21-00 Route 208 South, Suite 130 Fair Lawn, NJ 07410


Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
OpenAI Explores Massive Funding Round at $750 Billion Valuation
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group 



